Risedronate In The Prevention Of Osteoporosis In Osteopenic Postmenopausal Women

Clinical trial NCT00353080 · COMPLETED

Trial details

NCT number: NCT00353080
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Osteoporosis, Postmenopausal

Start date: 2002-12-01
Primary completion: 2005-04-01
Enrollment: 171

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.